Evaluation of chemosensitivity testing with highly purified tumor cells in 435 patients with gastric carcinoma using an MTT assay

Anticancer Research

Volumn 25, Issue 2 A, 2005, Pages 931-937

  Noguchi, Kohei ^a   Iwahashi, Makoto ^a   Tani, Masaji ^a   Nakamura, Masaki ^a   Nakamori, Mikihito ^a   Nakatani, Yoshihiro ^a   Ueda, Kentaro ^a   Ishida, Koichiro ^a   Naka, Teiji ^a   Ojima, Toshiyasu ^a   Hotta, Tsukasa ^a   Mizobata, Shizuma ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anticancer drugs; Chemosensitivity; Chemotherapy; Gastric cancer

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; 7 ETHYL 10 HYDROXYCAMPTOTHECIN GLUCURONIDE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IRINOTECAN; MITOMYCIN C;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER PATIENT; CELL DIFFERENTIATION; CHEMOSENSITIVITY; DRUG EFFICACY; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METASTASIS INHIBITION; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR CELL CULTURE;

CISPLATIN; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; STOMACH NEOPLASMS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 20244387297     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Chipponi J, Huguier M, Pezet D, Basso N, Hay JM, Quandalle P, Jaeck D, Fangniez PL and Gainant A: Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am J Surg 187: 440-445, 2004.
2. Koizumi W, Tanabe S, Saigenji, Ohtsu A, Boku N, Nagashima F, Shirao K, Matsumura Y and Gotoh M: Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 89: 2207-2212, 2003.
3. Kmieciak Le Corguille M, Petitjean B, Beaulieu S, Vitte RL, Tennenbaum R, Rocher P and Eugene C: Alpha-fetoprotein-producing poorly differentiated gastric adenocarcinoma: hepatoid carcinoma? Gastroenterol Clin Biol 28: 77-79, 2004.
4. Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M and Van de Velde CJ: Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 11: 1441-1447, 1993.
5. Macdonald JS: Advances in the therapy of gastric cancer. Gastric Cancer 5: 35-40, 2002.
6. Pyrhonen S, Kuitunen T, Nyandoto P and Kouri M: Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71: 587-591, 1995.
7. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA and Rausch M: Modified therapy with 5-fluorouracil, doxorubicin and methotrexate in advanced gastric cancer. Cancer 72: 37-41, 1993.
8. Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden PO, Haglund U, Svensson C, Enander LK, Linne T, Sellstrom H and Heuman R: Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8: 163-168, 1997.
9. Furukawa T, Kubota T and Hoffman RM: Clinical application of the histoculture drug response assay. Clin Cancer Res 1: 305-311, 1995.
10. Metzger R, Deglmann CJ, Hoerrlein S, Zapf S and Hilfrich J: Towards in-vitro prediction of an in vivo cytostatic response of human tumor cells with a fast chemosensitivity assay. Toxicology 166: 97-108, 2001.
11. Hanatani Y, Kobayashi H, Kodaira S, Takami H, Asagoe T and Kaneshiro E: An in vitro chemosensitivity test for gastric cancer using collagen gel droplet embedded culture. Oncol Rep 7: 1027-1033, 2000.
12. Yamaue H, Tanimura H, Noguchi K, Hotta T, Tani M, Tsunoda T, Iwahashi M, Tamai M and Iwakura S: Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay. Br J Cancer 66: 794-799, 1992.
13. Yamaue H, Tanimura H, Nakamori M, Noguchi K, Iwahashi M, Tani M, Hotta T, Murakami K and Ishimoto K: Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay. Dis Colon Rectum 39: 416-422, 1996.
14. Nakamori M, Iwahashi M, Nakamura M and Yamaue H: Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma. J Surg Oncol 84: 10-16, 2003.
15. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
16. Yamaue H, Tanimura H, Tsunoda T, Tani M, Iwahashi M, Noguchi K, Tamai M, Hotta T and Arii K: Chemosensitivity testing with highly purified tumour cells with the MTT colorimetric assay. Eur J Cancer 27: 1258-1263, 1991.
17. Suzuki T, Ochiai T, Nakajima K, Matsubara H, Arima M, Hori S, Hayashi H, Shimada H, Takeda A, Yanagawa T and Sen K: A feasibility study of chemosensitivity assay by adhesive tumor cell culture system using biopsy specimens for gastric cancer. J Surg Oncol 74: 141-147, 2000.
18. Abe S, Kubota T, Matsuzaki SW, Otani Y, Watanabe M, Teramoto T, Kumai K and Kitajima M: Chemosensitivity test is useful in evaluating appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancer. Anticancer Res 19: 4581-4586, 1999.
19. Preusser P, Wilke H, Achterrath W, Fink U, Lenaz L, Heinicke A, Meyer J, Meyer HJ and Buente H: Phase II study with the combination etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer. J Clin Oncol 7: 1310-1317, 1989.
20. Ridwelski K, Gebauer T, Fahlke J, Kroning H, Kettner E, Meyer F, Eichelmann K and Lippert H: Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer. Ann Oncol 12: 47-51, 2001.
21. Furukawa T, Kubota T, Watanabe M, Kuo TH, Kitajima M and Hoffman RM: Differential chemosensitivity of local and metastatic human gastric cancer after orthotopic transplantation of histologically intact tumor tissue in nude mice. Int J Cancer 54: 397-401, 1993.
22. Kusumoto H, Maehara Y, Kusumoto T, Anai H, Akazawa K and Sugimachi K: Chemosensitivity differences between primary and metastatic lesions of clinical gastric cancer. Eur J Surg Oncol 14: 685-689, 1988.
23. Maehara Y, Anai H, Kusumoto H and Sugimachi K: Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma. Eur J Surg Oncol 13: 203-206, 1987.
24. Kusumoto H, Maehara Y, Yoshida M, Takahashi I, Anai H and Sugimachi K: Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer. AntiCancer Drugs 3: 33-38, 1992.
25. 50 ratio. Anti-Cancer Drugs 6: 291-302, 1995.
26. Ulukan H, Muller MT and Swaan PW: Downregulation of topoisomerase I in differentiating human intestinal epithelial cells. Int J Cancer 15: 200-207, 2001.
27. Okada M, Kojima S, Murakami M, Fuchigami T, Yao T, Omae T and Iwashita A: Human gastric carcinoma: prognosis in relation to macroscopic and microscopic features of the primary tumor. J Natl Cancer Inst 71: 275-279, 1983.
28. Stathopoulos GP, Rigatos SK, Fountzilas G, Polyzos A and Stathopoulos JG: Paclitaxel and carboplatin in pretreated gastric cancer: A phase II study. Oncol Rep 9: 89-92, 2002.
29. Sakata Y, Ohtsu A, Horikoshi N, Sugimachi K, Mitachi Y and Taguchi T: Late phase II study of novel oral fluoropyrimidine anticancer drugs S-1 (1M tegafur-0.4M gimestat-1 M otastat potassium) in advanced gastric cancer. Eur J Cancer 34: 1715-1720, 1998.
30. Kondo T, Kubota T, Tanimura H, Yamaue H, Akiyama S, Maehara Y, Tanigawa N, Kitajima M, Takagi H and Japan Research Society for Appropriate Cancer Chemotherapy: Cumulative results of chemosensitivity tests for antitumor agents in Japan. Anticancer Res 20: 2389-2392, 2000.